Last reviewed · How we verify
NCT06644469
Whole Body Vibration in Middle Aged Men
NA trial testing Dynatronics VF5 Model vibration platform in Bone Density in 34 participants. Not yet recruiting.
1 December 2024
Quick facts
| Lead sponsor | Jouf University |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 34 |
| Start date | 15 October 2024 |
| Primary completion | 1 December 2024 |
| Estimated completion | 15 December 2024 |
| Sites | 1 location across Saudi Arabia |
Drugs / interventions tested
- Dynatronics VF5 Model vibration platform
- Placebo Dynatronics VF5 Model vibration platform
Conditions studied
- Bone Density — all drugs for Bone Density →
- Muscle Weakness — all drugs for Muscle Weakness →
Sponsor
Jouf University
Who can join
50 and older, male only, with Bone Density or Muscle Weakness. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims of this clinical trial is to evaluate the effect of an 8-week Whole Body Vibration (WBV) intervention on Bone Mineral Density (BMD), hand grip strength, and vitamin D levels in middle-aged men. Findings from this study will contribute to understanding whether WBV is a viable alternative to conventional exercise, especially for those with limitations in physical activity. Study Objectives: • Primary Objective: To assess the effectiveness of an 8-week WBV intervention in improving BMD, hand grip strength, and vitamin D levels compared to a placebo intervention.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06644469
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Bone Density
Currently open trials in the same condition.
- NCT07010146 — Role of Estrogen on Skeletal Outcomes in FHA · Phase 2 · recruiting
- NCT06903923 — Bone Metabolism in 12-21 Year Olds Undergoing Glucagon Like Peptide (GLP)-1 Receptor Agonist Therapy · Phase 2 · recruiting
- NCT06949280 — Metabolic Health, Bones and Nuts During Weight Loss in Adults · NA · recruiting
- NCT07031778 — Topic Simvastatin for Bone Regeneration · EARLY_PHASE1 · recruiting
- NCT06683222 — Mediating Role of Myokines in the Dialogue Between Muscle and Bone Tissue in a Population of Healthy Women Aged 20-89 Ye · NA · recruiting
Other Jouf University trials
Trials by the same sponsor.
- NCT07410858 — Virtual Reality-Enhanced Parent Education in Neonatal Intensive Care · NA · recruiting
- NCT06927882 — Effects of Whole Body Vibration Therapy on Cognitive Function, Balance, and Quality of Life in Older Adults With Mild Co · NA · not yet recruiting
- NCT07040384 — KEA vs Towel for Early Quad Activation Post Anterior Cruciate Ligament Reconstruction · NA · not yet recruiting
- NCT07002840 — Effect of Cross-legged Sitting Among Patients With Unilateral Hip Developmental Dysplasia · NA · not yet recruiting
- NCT07181252 — Comparison of Post-operative Pain in Relation to Working Length Assessment by Electronic Apex Locator and Digital Radiog · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06644469 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Jouf University
- Last refreshed: 18 October 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06644469.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing